Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

Brenda Snow
Authentic Patient Voice